A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma

Nutrition Research

Volumn 29, Issue 2, 2009, Pages 89-93

  Takeshita, Shigeyuki ^a   Ichikawa, Tatsuki ^a   Nakao, Kazuhiko ^a   Miyaaki, Hisamitsu ^a   Shibata, Hidetaka ^a   Matsuzaki, Toshihisa ^a   Muraoka, Toru ^a   Honda, Takuya ^a,b   Otani, Masashi ^a   Akiyama, Motohisa ^a   Miuma, Satoshi ^a   Ozawa, Esuke ^a   Fujimito, Masumi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Japanese Red Cross Nagasaki Atomic Bomb Hospital Nagasaki   (Japan)

Author keywords

Branched chain amino acid; Chemoembolization; Hepatocellular carcinoma; Human; Liver cirrhosis; Nutritional status

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; CHOLESTEROL; CHOLINESTERASE; EPIRUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN;

AGED; ARTICLE; CHEMOEMBOLIZATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE COUNT; FAST FOOD; FEMALE; FOOD INTAKE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL;

AGED; AMINO ACIDS, BRANCHED-CHAIN; AMMONIA; BLOOD PROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLESTEROL; CHOLINESTERASES; DIETARY SUPPLEMENTS; ERYTHROCYTE COUNT; FEMALE; FOOD, FORTIFIED; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 61749097334     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.12.005     Document Type: Article

References (34)

1. Bosch F.X., Ribes J., and Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 19 (1999) 271-285
2. Llovet J.M. Update treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225-235
3. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
4. Llovet J.M., Real M.I., Montana X., Planas R., Coll S., Aponte J., et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359 (2002) 1734-1739
5. London W.T. Primary hepatocellular carcinoma-etiology, pathogenesis, and prevention. Hum Pathol 12 (1981) 1085-1097
6. Lautz H.U., Selverg O., Körber J., Bürger M., and Müller M.J. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 70 (1992) 478-486
7. Müller M.J., Lauts H.U., Plogmann B., Bürger M., Körber J., and Schmidt F.W. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 15 (1992) 782-794
8. Crawford D.H., Shepherd R.W., Halliday J.W., Cooksley G.W., Golding S.D., Cheng W.S., et al. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology 106 (1994) 1611-1617
9. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 21 (1994) 317-335
10. Nielsen K., Kondrup J., Martinsen L., Døssing H., Larsson B., Stilling B., et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic cirrhosis. Br J Nutr 69 (1993) 665-679
11. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163 (1992) 387-394
12. Yamada R., Kishi K., Sonomura T., Tsuda M., Nomura S., and Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 13 (1990) 135-139
13. Stuart K., Stokes K., Jenkins R., Trey C., and Clouse M. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer 72 (1993) 3202-3209
14. Kajiwara K., Okuno M., Kobayashi T., Honma N., Maki T., Kato M., et al. Oral supplementation with branched chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 43 (1998) 1572-1579
15. Yoshida T., Muto Y., Moriwaki H., and Yamato M. Effect of long-term oral supplementation with branched chain amino acid granules on the prognosis of liver cirrhosis. J Gastroenterol 24 (1989) 692-698
16. Marchesini G., Dioguardi F.S., Bianchi G.P., Zoli M., Bellati G., Roffi L., et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double blind casein-controlled trial. J Hepatol 11 (1990) 92-101
17. Marchesine G., Bianchi G., Merli M., Amodio P., Panella C., Loguercio C., et al. Nutritional supplementation with branched chain amino acids in advanced cirrhosis: a doubled-blind, randomized trial. Gastroenterology 124 (2003) 1792-1801
18. Nakaya Y., Okita K., Suzuki K., Moriwaki H., Kato A., Miwa Y., et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 23 (2007) 113-120
19. Hisataka M., Yoshiyuki M., Masahiro T., Masahiko K., Hideki F., Makoto S., et al. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313 (2004) 405-409
20. Tomiya T., Omata M., and Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commun 313 (2004) 411-416
21. Poon R.T., Yu W.C., Fan S.T., and Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 19 (2004) 779-788
22. Kudo M., Okanoue T., and Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72 suppl 1 (2007) 2-15
23. Okamoto M., Sakaida I., Tsuchiya M., Suzuki C., and Okita K. Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res 27 (2003) 45-50
24. Tsuchiya M., Sakaida I., Okamoto M., and Okita K. The effect of late evening snack in patients with liver cirrhosis. Hepatol Res 31 (2005) 95-103
25. Merli M., Riggio O., and Dally L. Does malnutrition affect survival in cirrhosis?. Hepatology 23 (1996) 1041-1046
26. Andersen H., Borre M., Jakobsen J., Andersen P.H., and Vilstrup H. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to malnutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 27 (1998) 1200-1206
27. Yoshida T., Muto Y., Moriwaki H., and Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. J Gastroenterol 24 (1989) 692-698
28. Ijichi C., Matsumura T., Tsuji T., and Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 303 (2003) 59-64
29. Okuno M., Moriwaki M., Kato M., Muto S., and Kojima S. Changes in the ratio of branched-chain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes. Biochem Biophys Res Commun 214 (1995) 1045-1050
30. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
31. Meng W.C., Leung K.L., Ho R.L., Leung T.W., and Lau W.Y. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 69 (1999) 811-815
32. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br J Surg 84 (1997) 1525-1531
33. Yamamoto M., Iwasa M., Matsumura K., Nakagawa Y., Fujita N., Kobayashi Y., et al. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 11 (2005) 6792-6799
34. Nakamura I., Ochiai K., Imai Y., Moriyasu F., and Imawari M. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 37 (2007) 1062-1067